More articles from MTA I: Radiopharmaceutical Therapy Posters

You have access
Effects of different doses 177Lu-EDTMP for painful bone metastases from prostate and breast cancer
Xingdang Liu, Jie Yuan, Congjin Liu, Hongyu Li, Zhifu Luo and John Zaknun

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1210;
You have access
Toxicity of sequential treatment with radioembolization and PRRT in hepatic metastasized neuroendocrine tumors
Julia Geisler, Christoph Auernhammer, Christoph Zech, Peter Bartenstein, Marcus Hacker and Alexander Haug

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1189;
You have access
Efficacy of peptide receptor radionuclide therapy (PRRT) as first or second line treatment in advanced metastatic gastric NET
Vikas Prasad, Helga Bertram, Ulrich-Frank Pape, Christian Rosner, Bertram Wiedenmann, Marianne Pavel and Winfried Brenner

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1215;
You have access
An extended 28-day acute toxicity study of 188Re-liposome in rats
Chia-Che Tsai, Chih-Hsien Chang and Te-Wei Lee

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1207;
You have access
Is peptide receptor radionuclide therapy an option after liver transplantation in progressive metastatic neuroendocrine tumors?
Harshad Kulkarni, Daniel Kaemmerer, Dieter Hoersch, Merten Hommann and Richard Baum

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1177;
You have access
Repeated radioimmunotherapy (RIT) with 131I-rituximab for patients with low grade and aggressive relapsed/refractory B-cell non-Hodgkin’s lymphoma (NHL)
Hye Jin Kang, Seung-Sook Lee, Kyeong Min Kim and Sang Moo Lim

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1198;
You have access
Tumor response assessment to treatment with [¹⁷⁷Lu-DOTA⁰,Tyr³]octreotate in patients with gastroenteropancreatic neuroendocrine tumors: Differential response of bone versus soft tissue lesions
Esther van Vliet, John Hermans, Maria de Ridder, Jaap Teunissen, Boen liong Kam, Ronald de Krijger, Eric Krenning and Dik Kwekkeboom

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1181;
You have access
The influence on rat’s thyroid weight and function by applying nicotinamide with 131I
Jin Jianhua, Li Xiaomin, Niu Rong, Fu Songhai, Liu Ye and Li Sijin

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1212;
You have access
Accurate assessment of long-term nephrotoxicity after therapy with 177Lu-octreotate
Amir Sabet, Khaled Ezziddin, Karl Reichmann, Hojjat Ahmadzadehfar, Torjan Haslerud, Stefan Guhlke, Hans Jürgen Biersack and Samer Ezziddin

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1186;
You have access
Radiation dosimetry of glass versus resin Y-90 microsphere radioembolization in patients with colorectal liver metastases
Vamsi Kunam, Sankaran Shrikanthan and Shyam Srinivas

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1203;

Main menu

User menu

Search

More articles from MTA I: Radiopharmaceutical Therapy Posters

Pages